Showing results (1801-1810 of 2,133) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|September 24, 2004
Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in ratsKota Jagannath, Madhusudana Rao Chaluvadi, Ramesh Mullangi, et al.Biopharmaceutics & Drug Disposition|January 1, 1995
The estimation of the plasma free fraction of cyclosporine in rabbits and heart transplant patients: the application of a physiological model of renal clearanceA K Shah, R C Brundage, K D Lake, et al.Biopharmaceutics & Drug Disposition|March 1, 1995
Kinetic modelling of liposome degradation in peritoneal macrophagesH Harashima, N Hirai, H KiwadaBiopharmaceutics & Drug Disposition|March 1, 1995
Disposition kinetics of HEPP in rats after intravenous, oral, and intraperitoneal administration. Correlation of plasma and brain levels with the anticonvulsant effectL E Gómez, R Cueva-Rolón, P A LehmannBiopharmaceutics & Drug Disposition|October 1, 1994
Plasma pharmacokinetics and urinary and biliary excretion of a new potent tripeptide HIV-1 protease inhibitor, KNI-272, in rats after intravenous administrationA Kiriyama, K Fujita, S Takemura, et al.Biopharmaceutics & Drug Disposition|April 1, 1995
Pharmacokinetics of amoxicillin coadministered with a saline-polyethylene glycol solution in healthy volunteersC Padoin, M Tod, N Brion, et al.Biopharmaceutics & Drug Disposition|April 1, 1995
Pharmacokinetics of dolasetron following single- and multiple-dose intravenous administration to normal male subjectsA Shah, R Lanman, V Bhargava, et al.Biopharmaceutics & Drug Disposition|April 1, 1995
Pharmacokinetic analysis of diethylcarbonate prodrugs of ibuprofen and naproxenE Samara, D Avnir, D Ladkani, et al.Biopharmaceutics & Drug Disposition|April 1, 1995
Disposition of [3H]fluvastatin following single oral doses in beagle dogs and rhesus monkeys with bile fistulaeF L Tse, J G Dain, G KalafskyBiopharmaceutics & Drug Disposition|August 1, 1994
The absence of a pharmacokinetic interaction between aspirin and the angiotensin-converting enzyme inhibitor benazepril in healthy volunteersA Sioufi, F Pommier, N Gauducheau, et al.Pageof 214